Category: Health Services

GENEVA: A new oral vaccine for cholera has received prequalification by the World Health Organisation (WHO). The inactivated oral vaccine Euvichol-S has a similar efficacy to existing vaccines but a simplified formulation, allowing opportunities to rapidly increase production capacity.

‘The new vaccine is the third product of the same family of vaccines we have for cholera in our WHO prequalification list,’ said Dr Rogerio Gaspar, Director of the WHO Department for Regulation and Prequalification. ‘The new prequalification is hoped to enable a rapid increase in production and supply which many communities battling with cholera outbreaks urgently need.’

WHO prequalification list already includes Euvichol and Euvichol-Plus inactivated oral cholera vaccines produced by EuBiologicals Co., Ltd, Republic of Korea, which also produces the new vaccine Euvichol-S.

Vaccines provide the fastest intervention to prevent, limit and control cholera outbreaks, but supplies have been at the lowest point amidst countries fa
cing dire shortcomings in other areas of cholera prevention and management such as safe water, hygiene and sanitation.

There were 473,000 cholera cases reported to WHO in 2022 — double the number from 2021. Further increase of cases by 700,000 was estimated for 2023. Currently, 23 countries are reporting cholera outbreaks with most severe impacts seen in the Comoros, Democratic Republic of the Congo, Ethiopia, Mozambique, Somalia, Zambia and Zimbabwe.

Source: Emirates News Agency

DUBAI: Under the patronage of Sheikh Nahyan bin Mubarak Al Nahyan, Minister of Tolerance and Coexistence, Dubai will tomorrow host the 7th Emirates Family Medicine Society Congress 2024.

The event will take place at the Dubai World Trade Centre from 22nd to 24th April. Notably, it stands as the premier annual gathering for family medicine within the GCC and the broader Middle East region.

The congress edition for this year will feature key topics such as artificial intelligence in family medicine, metaverse in family medicine, and primary care centers. The event will see notable attendance from leaders of the Dubai Health Authority, the Emirates Genetic Diseases Association, a selection of physicians and officials from the Gulf Cooperation Council and the Middle East, as well as international speakers from the American Academy of Family Physicians.

Organised by the Emirates Family Medicine Society under the umbrella of the Emirates Medical Association, and in collaboration with Dubai Health Authority, repr
esented by the presence of Awadh Seghayer Al Ketbi, Director General (DHA), Dr. Marwan Al Mulla, CEO of the Health Regulation Sector (DHA), Dr. Ahmed Al Neaimi, CEO of Corporate Shared Support Services Sector (DHA), Fatima Abbas. CEO of Strategy and Corporate Development Sector (DHA), and Mr. Saleh Al Hashimi, CEO of Dubai Health Insurance Corporation, alongside a selection of doctors and officials, as well as heads of family medicine societies and associations from the Gulf Arab region and the Middle East, and international speakers from the American Academy of Family Physicians, who have been participating in this congress since its previous editions. The congress is also honored by the participation and attendance of Dr. Maryam Matar, the Founder and Chairperson, UAE Genetic Diseases Association.

This year’s edition of the conference will focus on the role of artificial intelligence and metaverse in the healthcare sector in general, and family medicine in particular. This comes in line with the UAE’s dire
ction towards AI and digital medical services, recognising these technologies as cornerstone in advancing and improving healthcare services. The Ministry of Health and Prevention has formulated a comprehensive plan to integrate AI by 100% into medical services, aligning with the core and the goals of the UAE’s AI strategy and the UAE Centennial 2071 vision to transform healthcare services provided for patients.

Prof Dr. Wadeia Mohammed, President of the Emirates Family Medicine Society, expressed pleasure in hosting a distinguished array of personalities, leaders, and experts at the 7th Emirates Family Medicine Society Congress, a significant annual event attracting attendees from across the region and the world to exchange experiences and insights for the future of family medicine, reinforcing best practices in the field. especially since this medical specialty is considered the backbone of the healthcare sector.

Dr. Wadeia added, ‘The topic of artificial intelligence will be prominently featured in this y
ear’s edition of the conference with an aim to highlight the role of these revolutionary technologies in the medical field in general, and family medicine in particular, and to review best practices for their use in a way that benefits patients, enhances their experience, supports healthcare professionals, and enables them to achieve the best therapeutic outcomes for patients.’

Since its inception in 2018, the congress has achieved remarkable success, witnessing a continuous increase in attendance and participation. The aim of the Emirates Family Medicine Society with this congress is to shed light on global advancements in family medicine and the latest methods of prevention, diagnosis, treatment, and innovative technologies in this field.

Source: Emirates News Agency

ABU DHABI: Reflecting the emirate’s ambitions to a healthier future for all, the Department of Health – Abu Dhabi (DoH), the regulator of the emirate’s healthcare sector, in collaboration with Abu Dhabi Public Health Centre (ADPHC), has supported over 353 Abu Dhabi-based couples in making informed health decisions before marriage through the expanded genetic screening within the premarital screening services provided across the primary healthcare centres.

Recent data underscores the screening’s positive impact, with 353 couples having enrolled, an impressive 85 percent achieved genetic compatibility, and only 15 percent required additional family planning interventions based on genetic results. The screening programme translates both DoH and ADPHC’s efforts in elevating the healthcare journey of couples early on throughout the different phases, including diagnostic, genetic counselling, and introducing reproductive medicine solutions.

In 2022, the DoH and ADPHC incorporated an optional genetic screening in
the premarital screening programme as part of proactive preventive measures to safeguard the health and well-being of community members. By detecting and preventing genetic conditions, genetic screening hinders the transmission of a certain group of hereditary diseases and ultimately leads to a healthier Abu Dhabi community. Offered in more than 22 healthcare facilities across Abu Dhabi, the comprehensive genetic screening tests for autosomal recessive 570 genes contribute to over 840 genetic disorders.

Dr. Asma Al Mannaei, Executive Director of the Research and Innovation Centre at the DoH, said, ‘Recognising the importance of genomics in making informed decisions, Abu Dhabi’s proactive approach places it at the forefront of leading healthcare systems around the world. Integrating genetic tests into premarital screening in Abu Dhabi surpasses the global trend of pushing genomics into mainstream healthcare, paving the way for more precise and effective medicine. The DoH remains committed to empowering commun
ity members with data and insights that can support them in making informed decisions to manage their health and address potential risks early on.’

Dr. Omniyat Al Hajeri, Executive Director of Community Health Sector at Abu Dhabi Public Health Centre (ADPHC) said, ‘This project underscores the Abu Dhabi Public Health Centre’s dedication, in partnership with its strategic stakeholders, to establish preventative genetic screening approach and support in identifying high-risk couples by introducing the genetic testing and therefore facilitating discussion on assisted intervention options and follow up the referral to the IVF centres as needed in the future. Our objective through this initiative is to proactively prevent the transmission of certain groups of genetic conditions to the next generation while providing the support needed to empower individuals in regard to future decisions.’

The department continues to leverage the emirate’s advanced healthcare infrastructure and innovative ecosystem to utilise DNA
sequencing technology to foresee medical conditions among individuals and encourage the translation of advanced genetic data provided through the Emirati Genome Programme into clinical practice.

While genetic compatibility plays a significant role in ensuring the long-term health and well-being of future generations, the DoH encourages couples to undergo premarital genetic screening and include it in their marriage plans to support them in early detection, risk mitigation, and family planning.

Source: Emirates News Agency

ABU DHABI: PureHealth, the largest healthcare platform in the Middle East, and subsidiary Abu Dhabi Health Services Company (SEHA), are set to redefine children’s health services with the launch of a Paediatrics Centre in collaboration with world-renowned Cincinnati Children’s, ranked first in the United States for paediatric care.

The collaboration is poised to establish a Paediatric Centre of Excellence (CoE), further reinforcing Abu Dhabi’s position as a leading healthcare destination.

The announcement follows an earlier approval by H.H. Sheikh Khaled bin Mohamed bin Zayed Al Nahyan, Crown Prince of Abu Dhabi and Chairman of Abu Dhabi Executive Council, to establish a specialised medical city dedicated to the health of women and children. Within this framework, SEHA’s Sheikh Khalifa Medical City (SKMC) has already earned designation as a Centre of Excellence for paediatric heart care, providing babies and children with congenital heart diseases and related complications with comprehensive medical care wi
thin the local community and globally.

Shaista Asif, Group CEO of PureHealth, said, ‘At PureHealth, our heart lies in nurturing the future of Abu Dhabi by ensuring our children, the cornerstone of tomorrow, receive the best possible start in life. Our commitment extends beyond just medical treatment. It’s about crafting a healthier, brighter future for our youngest generation. By establishing the Centre of Excellence for Paediatrics in collaboration with SEHA and Cincinnati Children’s, we are not just advancing healthcare; we are investing in the lives and longevity of our children.

‘As the largest healthcare platform in the Middle East, PureHealth, in collaboration with our partners, is dedicated to integrating cutting-edge technology and compassionate care to enhance our children’s health and life spans. Together, we are crafting a legacy of health, empowering our children to lead the charge toward a more hopeful, vibrant future,’ she added.

With research and innovation in paediatric medicine a key focus
, the aim is to facilitate the development of new treatments and therapies, ultimately improving outcomes for children with complex medical conditions. Under the agreement, Cincinnati Children’s will deliver services to the centre, which comprises an acute care hospital providing specialised services such as paediatric oncology and haematology, paediatric nephrology, paediatric metabolic disorders, and paediatric minimally invasive procedures.

The establishment of the Paediatric Centre in Abu Dhabi marks a significant step forward in healthcare, particularly in providing access to highly skilled physicians and fostering the upskilling of the local workforce. This initiative underscores Abu Dhabi’s commitment to creating a sustainable healthcare environment by integrating cutting-edge technology, innovation, and research.

By facilitating collaboration between local and international experts, the centre is set to enhance the proficiency and expertise of healthcare professionals in the region, ensuring that re
sidents have access to world-class paediatric care. Furthermore, the presence of this centre within the local community will substantially reduce the need for families to travel abroad for complex medical procedures and follow-ups, bringing world-class healthcare services to Abu Dhabi.

Saeed Jaber Al Kuwaiti, Group CEO, SEHA, said, ‘We are proud to partner with Cincinnati Children’s, reinforcing our commitment to aligning with local healthcare services while maintaining the highest international standards. This centre is poised to set a new benchmark in paediatric care quality, reflecting the UAE’s dedication to the well-being of the youngest members of the community. We are confident that the partnership will elevate the healthcare ecosystem in Abu Dhabi, further enhancing local capabilities in medicine, research, and innovation.’

‘At Cincinnati Children’s, we believe that access to the highest quality care should be available to every child. Collaboration is part of who we are, and we know that by working
with SEHA and PureHealth to share our knowledge and experience, together we are creating a brighter future for children here and around the world,’ said Steve Davis, MD, MMM, Cincinnati Children’s President and CEO.

Source: Emirates News Agency

ABU DHABI: The National Multiple Sclerosis Society (NMSS) concluded its Move for MS initiative, which ran throughout the holy month of Ramadan, coinciding with MS Awareness Month.

The initiative aimed to support people living with MS by encouraging participation in inclusive sports and physical activities. 2,900 individuals in the UAE participated in the community challenge, including those employed by Move for MS’ corporate partners. Participants collectively contributed 426,526,815 steps, which is equivalent to 296,693 kilometres. This equates to walking the circumference of the Earth seven times.

Dr. Fatima Al Kaabi, Vice Chair of the NMSS, Director-General of Emirates Drug Establishment, and Executive Director of the Abu Dhabi Bone Marrow Transplant program at Abu Dhabi Stem Cells Centre (ADSCC), said, “As the ‘Move for MS’ initiative draws to a close, I am immensely grateful to the UAE community’s response and strong show of solidarity. Together, we have made significant strides in raising awareness an
d garnering much-needed support for people living with MS. The success of this initiative underscores the power of community and the importance of standing united in our mission to make a meaningful difference in the lives of those affected by MS.”

Several high-profile government and corporate organizations participated in the Move for MS initiative, including Mubadala, Abu Dhabi Stem Cells Center (ADSCC), ADQ, Cleveland Clinic Abu Dhabi, Ma’an, and Lulu Group. These partners played a pivotal role in encouraging their employees to participate, resulting in the involvement of nearly 1000 employees from all participating entities.

The Move for MS campaign was supported by fitness partners Inspire Sports, YogaOne Studio, Motion Cycling, Chapter Studio, The Bridge Wellness Hub, Seven Wellness Club, Breathes Wellness, Pilatiq Fitness Studio, and CRANK Fitness. The studios and gyms generously donated proceeds from designated classes to support NMSS initiatives.

At the heart of the Move for MS initiative is the o
verarching goal of empowerment through movement and community solidarity for people with MS. This objective aligns with NMSS’ mission of raising awareness, promoting understanding, and dispelling misconceptions surrounding MS while also securing essential funds for ongoing support and research efforts.

Multiple Sclerosis (MS) is a chronic, unpredictable condition of the central nervous system that disrupts the flow of information between the brain and spinal cord. The cause of MS is unknown. Around 19 in every 100,000 people are affected by MS in the UAE. Females are twice as likely to have MS. 67 percent of women vs 33 percent of men.

Source: Emirates News Agency

ABU DHABI: Cleveland Clinic Abu Dhabi, part of the M42 group, is set to host two significant global medical summits on complex oncology care and advancements this April. The Cleveland Clinic Global Summit on Innovations in Cancer Care and Frontiers in Advanced Hepato-Biliary Cancers and Transplant Oncology will convene over 50 oncology and digestive diseases experts from Cleveland Clinic worldwide, affirming the hospital’s pivotal role as a global force in medical education and innovation.

The inaugural event, the Cleveland Clinic Global Summit on Innovations in Cancer Care, scheduled from 19th-21st April at the Four Seasons Hotel, Abu Dhabi, UAE, will be led by Dr. Faek Jamali, Consultant Surgical Oncologist and Colorectal Surgeon at Cleveland Clinic Abu Dhabi. The internationally recognised, CME-accredited summit by the European Accreditation Council for Continuing Medical Education (EACCME) will cover a diverse array of topics, including cancer screening and prevention, and updates in surgical and radiati
on oncology. The gathering of world-renowned oncology experts at the annual global platform will address the spike in cancer detection amongst an increasingly growing younger population, as reported by several international studies. A special session on global oncology will also put a spotlight on the unique challenges and opportunities for enhancing cancer care in the Middle East.

Additionally, the event will hold its inaugural annual award ceremony to pay tribute to global champions and influencers who have demonstrated unwavering dedication to driving awareness and advancing cancer care.

The second event, Frontiers in Advanced Hepato-Biliary Cancers and Transplant Oncology, slated for 27th-28th April at Cleveland Clinic Abu Dhabi, led by Dr. Cristiano Quintini, Institute Chair, General Surgery, Digestive Disease Institute, and CME accredited by Accreditation Council for Continuing Medical Education (ACCME) via Cleveland Clinic Abu Dhabi, aims to bring together leading experts in transplant and hepatic, b
iliary, oncological diseases, to discuss cutting-edge interventions and innovations in the field. The event will also see the launch of the annual Resident Surgery Education Week, where residents from all around the UAE will get practical hands-on skills and guidance from world-renowned surgeons, learning tips and tricks of specific surgical techniques. The program will also include career planning and life lessons that are invaluable for young surgeons.

From the transformative role of genomics in cancer detection and treatment to insights into industry perspectives transcending geographical boundaries, these global summits promise to redefine the trajectory of oncological care. To cap this global summit, attendees will have the opportunity to exclusively tour the first of its kind, Fatima bint Mubarak Cancer Center, modelled on Cleveland Clinic’s Taussig Cancer Center- ranked one of the top cancer facilities in the US.

Source: Emirates News Agency